Tonix Pharmaceuticals Stock price Nasdaq
Equities
TNXP
US8902608624
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3222 USD | -2.36% | +2.32% | -20.05% |
Financials (USD)
Sales 2023 * | 10.3M | Sales 2024 * | 22.8M | Capitalization | 19.16M |
---|---|---|---|---|---|
Net income 2023 * | -115M | Net income 2024 * | -78M | EV / Sales 2023 * | 1.86 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.84 x |
P/E ratio 2023 * |
-0.04
x | P/E ratio 2024 * |
-0.1
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.99% |
1 day | -2.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+7.83% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |
- Stock
- Equities
- Stock Tonix Pharmaceuticals Holding Corp.
- Stock Tonix Pharmaceuticals - Nasdaq